It is believed that TGFBR2 plays a role involved in the occurrence and development of tumors, including NSCLC (36), pancreatic cancer (37), colorectal cancer (38), and liver cancer (39). This evidence concerns the gene TGFBR2 and pancreatic neoplasm.